Continous positive engagement results in stable levels of HVPCI
July 23, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
Regulatory decision-making depends on evidence that reflects how medical products perform in real-world use, not only in controlled trials. For more than a decade, the Food and Drug Administration has relied on real-world data and real-world...
July 23, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
This week’s webinar, VBA 2.0 Building and accelerating VBA for the next era, offered a deeper look...
April 30, 2020 - Philadelphia, PA -HealthVerity announced the biweekly update to its HealthVerity...
July 9, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
Value-based agreements unite pharma companies and payers with a mutually beneficial payment model,...
Throughout the past quarter, we’ve announced major collaborations, built on existing partnerships...
June 25, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
June 11, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
May 28, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
May 14, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists trea...